Keyword: patent expiries

News

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

30.06.2014 - The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...

News

Pfizer Chases AstraZeneca for Potential $100 billion Deal

29.04.2014 - Pfizer is now expected to increase its $100 billion offer to acquire UK rival AstraZeneca after being rebuffed a second time. The company has confirmed that it approached its...

News

Novartis Overhauls Japanese Unit after Drug Scandal

07.10.2013 - Novartis said it had overhauled management operations and sanctioned key staff in Japan after a scandal involving research into its Diovan blood pressure drug in the country. The...

News

Astrazeneca CEO Gets Two Cheers after First Year in Job

01.10.2013 - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...

News

Amgen Buys Onyx for $10.4 Billion

26.08.2013 - Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...

News

Eli Lilly Defends Blockbuster Alimta With Unusual Ammo

20.08.2013 - Eli Lilly, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds and wins a closely watched patent battle...

News

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

02.08.2013 - British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...

News

AstraZeneca to Axe 1,600 Jobs in Overhaul of Drug R&D

18.03.2013 - AstraZeneca is to cut around 1,600 jobs as it overhauls research operations and consolidates drug development work in three major centres in Britain, the United States and Sweden...